Mathews Journal of Immunology & Allergy

2575-9523

Previous Issues Volume 5, Issue 1 - 2021

Review Article PDF  

Literature Review of the Published Human Clinical Trials: On COVID-19 Vaccines

Sarah El-Nakeep

Sarah El-Nakeep

Internal Medicine Department, Faculty of Medicine, Ainshams University, Cairo, Egypt

Corresponding author: Sarah El-Nakeep, MD, Internal Medicine Department, Faculty of Medicine, Ainshams University, Cairo, Egypt, E-mail: sarahnakeep@yahoo.com.

Received Date: January 20, 2021

Published Date: February 16, 2021

Citation: Sarah El-Nakeep. (2021). Literature Review of the Published Human Clinical Trials: On COVID-19 Vaccines. Mathews J Immunol Allergy. (5)1:11.

Copyright: Sarah El-Nakeep. © 2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Background: With the release of two vaccines after FDA approval, we are entering phase IV or as it is called Post-marketing phase. This phase is responsible for the mass vaccination and the herd immunity we need to end the pandemic.

Methods: the author searched PubMed for the keywords “Vaccine, COVID-19, and SARS-CoV2”, along with following the announcements of the various scientific communities.

Results: No phase IV trial data has been published till the time being, but only published data of Phases I-II and III were found by the literature search. The author discussed the limitations of the studies and the promised outcomes measured in those studies.

Conclusions: Waiting for phase IV data yet to be published; the author has examined the benefits and limitations of each vaccine. 


© 2015 Mathews Open Access Journals. All Rights Reserved.

Creative Commons License
Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com

Watsapp